
Women receive less than 3% of VC funding.
LET'S CHANGE THE RATIO!
Finalists
.png)
Andrea
Diaz Baquero
CEO & Founder | Cosito
Build no-code sensor apps in minutes
​
MIT IDM 2021
Cosito helps people build no-code sensor applications for the physical world, with ready-to-use sensors. Just describe what you want to monitor, and Cosito will handle the rest. Cosito's AI-powered platform transforms real-world sensor data into actionable insights—whether it's monitoring temperature, humidity, assistance requests, logging activities, and more.

Andrea
Foncerrada
CEO | PolicyMind
The domain-specific AI for governments and policy consultants
MIT Sloan EMBA 2025
PolicyMind is a specialized artificial intelligence platform designed exclusively for the public policy sector. Our system integrates comprehensive policy knowledge, regulations, and governance to deliver targeted insights and streamlined solutions for complex policy challenges. At the intersection of policy, business, and AI, PolicyMind analyzes the world’s collective policy intelligence to generate evidence-based policy recommendations with unprecedented precision and contextual awareness. Unlike general-purpose AI, our system understands the nuances of policymaking, regulatory requirements, and implementation constraints. Further, PolicyMind transforms policy development through intelligent automation while preserving human judgment and expertise. We provide specialized tools that modern governance demands in an increasingly complex world.

Anisha
Quadir
Co-founder & CEO | livvi
The IRL Female Super Connector
​
MIT Sloan MBA 2023
Livvi is a platform connecting women IRL in a way they actually prefer: through small, compatible group matches. Its algorithm matches women into groups of 5-8 & its concierge recommends places to meet based on the group’s preferences, schedules & locations. Female friendships are essential for women’s health, career mobility, and happiness, yet 42% of adults struggle to make friends. Founders Anisha and Madeleine met at MIT and saw a gap in the market addressing the loneliness epidemic—most solutions focus on events, not meaningful connections. Livvi flips the script by finding women compatible matches first, understanding that women aren’t just looking for places to go—they are looking for the right people to go WITH. After their pitch went viral on TikTok and Instagram with over 1M views, demand skyrocketed from women around the world. They're now expanding into new cities to help women live healthier and happier lives together.

Erin
Dawicki
CEO | LymeAlert
Crushing Lyme Disease One Tick at a Time
​
MIT Sloan SFMBA 2024
LymeAlert is the first truly at-home tick testing kit for Lyme and other tick-borne diseases. Our all-in-one test kit allows you to test a tick anywhere, anytime and know in less than 20 minutes if your tick carries disease or not. It's simple. Find a tick, place it into our crushing device and crush it! Insert the test strip that works just like a Covid test. Scan the results with our app and this will tell you if your tick carries disease or not and what steps you should take next. Knowing you've been exposed to Lyme allows you to get rapid treatment that prevents disease. The results data will allow us to create hot spot maps, and our AI will predict where tick diseases are spreading next allowing us to help with disease prevention. Ticks suck. Crush them with LymeAlert.

Haining
Gao
Co-founder | HaloGen Power
Powering the Future: Smaller, Lighter, Longer-Lasting Primary Battery
MIT Course 3 PhD 2022
Primary (non-rechargeable) batteries have energy density three times higher than Li-ion, thus are critical when recharging is impractical, such as in many implantable/wearable medical devices and IoT sensors. In these devices, high-energy batteries are the key to enabling long device life and advanced functions. Despite increasing demand for higher energy primary batteries, there have been few innovations in fundamental cell chemistries for 40 years. HaloGen’s patent-pending battery can boost the energy density of state-of-the-art by 50%, while also improving safety, with little/no increase in cost.

Kat
Tarasova
Founder & CEO | Mycsology FoodsSustainable, Nutrient-Rich Ingredients
MIT Microbiology Course 7 PhD 2016
Mycsology Foods is developing minimally processed and nutrient-dense ingredients to power the next generation of healthy, clean-label snacks and convenience foods. Mycsology’s platform optimizes traditional microbial solid-state fermentation using high-throughput screening and predictive modeling to transform plant material inputs into shelf-stable ingredients. Our bespoke superblends are created at a fraction of the water and energy cost of comparable ingredient production methods and can be customized for use in a variety of consumer food products.

Katerina
Boukin
Co-founder | Flood Dynamics
Revolutionizing Urban Flood Resilience
MIT SM 2020, MIT PhD 2025, MIT PostDoc Associate (present)
Flood Dynamics is transforming urban flood resilience through advanced hydrodynamic modeling, machine learning-based risk assessment, and real-time data analytics. Unlike competitors, we uniquely model rain-driven flash flooding and its impact on pavement damage—critical blind spots in traditional flood forecasting. Our platform enables cities, insurers, and developers to accurately predict and proactively manage flood risks, minimizing damage and maximizing preparedness. We deliver high-impact insights that inform smarter infrastructure investments and long-term planning. Beyond forecasting, we offer integrated financial and policy solutions that help stakeholders adapt to the increasing frequency of extreme weather events. By fusing cutting-edge technology with practical, data-driven strategies, Flood Dynamics is not only helping communities weather the storm—we’re building a resilient future.

Samira
Kiani
Co-founder & COO | Hexem Bio
Reverse Aging with Advance Stem Cell Therapies
MIT Synthetic Biology Center PostDoc 2012-2015
HeXem Bio is pioneering cell and blood rejuvenation therapeutics to combat aging and disease. Our platform harnesses cutting-edge gene circuits and regenerative medicine to restore cellular function, extend healthspan, and unlock new frontiers in longevity science. With innovations published in Nature and deep expertise in synthetic biology, we develop fast, scalable solutions for reversing aging at the cellular level. Backed by top investors and scientific leaders, HeXem Bio is accelerating the future of regenerative therapeutics.